Publication | Closed Access

O119 : Stopping tenofovir disoproxil fumarate (TDF) treatment after long term virologic suppression in HBeAg-negative CHB: Week 48 interim results from an ongoing randomized, controlled trial (“finite CHB”)

Week 48PharmacologyClinical TrialsHepatitisAntiviral TherapyInterim ResultsPharmacotherapyAntiviral DrugMedicineTenofovir Disoproxil Fumarate